ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Synergy Pharmaceuticals
0.0300
0.0000
成交量：
- -
成交額：
- -
市值：
744.11萬
市盈率：
-0.05
高：
0.0300
開：
0.0300
低：
0.0300
收：
0.0300
52周最高：
2.24
52周最低：
0.0300
股本：
2.48億
流通股本：
2.47億
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.5617
每股收益(LYR):
-0.9951
淨資產收益率：
--
總資產收益率：
--
市淨率：
-0.08
市盈率(LYR):
-0.03
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Synergy Pharmaceuticals
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.synergypharma.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Synergy Pharmaceuticals Inc.於2005年11月15日在佛羅里達州註冊成立，是一家生物製藥公司，主要集中於藥物來治療胃腸道的障礙和疾病的發展。公司主導候選產品是首款治療女性慢性便秘口服藥（plecanatide），一個一種鳥苷酸環化酶C(GC-C)受體激動劑，用於治療胃腸道疾病，主要是慢性特發性便秘，或慢性特發性便秘和便秘型腸易激綜合征，或腸易激綜合征-C。慢性特發性便秘和腸易激綜合征-C是折磨全世界數百萬患者的功能性胃腸病。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SGYP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SGYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","market":"US","secType":"STK","nameCN":"Synergy Pharmaceuticals","latestPrice":0.03,"timestamp":1552680000000,"preClose":0.03,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":247204738,"shares":248037301,"eps":-0.561684,"marketStatus":"盤後交易","change":0,"latestTime":"03-20 17:23:30 EDT","open":0.03,"high":0.03,"low":0.03,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.561684,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774051200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.03,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","floatShares":247204738,"roa":"--","roe":"--","lyrEps":-0.995115,"shares":248037301,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.03,"low":0.03,"week52Low":0.03,"pbRate":"-0.08","week52High":2.235,"institutionHeld":0,"latestPrice":0.03,"eps":-0.561684,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.561684,"open":0.03,"prevYearClose":0.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGYP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"SGYP","fiscalQuarterEnding":"2018/09","expectedEps":-0.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2018-08-07","symbol":"SGYP","fiscalQuarterEnding":"2018/06","expectedEps":-0.17,"name":null,"time":"","type":"earning","dateTimestamp":1533614400000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2018-05-10","symbol":"SGYP","fiscalQuarterEnding":"2018/03","expectedEps":-0.17,"name":null,"time":"盤後","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2018-03-01","symbol":"SGYP","fiscalQuarterEnding":"2017/12","expectedEps":-0.19,"name":null,"time":"盤後","type":"earning","dateTimestamp":1519880400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2017-11-09","symbol":"SGYP","fiscalQuarterEnding":"2017/09","expectedEps":-0.27,"name":null,"time":"盤後","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGYP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.synergypharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0059},{"period":"1year","weight":0.1634},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Synergy Pharmaceuticals Inc.於2005年11月15日在佛羅里達州註冊成立，是一家生物製藥公司，主要集中於藥物來治療胃腸道的障礙和疾病的發展。公司主導候選產品是首款治療女性慢性便秘口服藥（plecanatide），一個一種鳥苷酸環化酶C(GC-C)受體激動劑，用於治療胃腸道疾病，主要是慢性特發性便秘，或慢性特發性便秘和便秘型腸易激綜合征，或腸易激綜合征-C。慢性特發性便秘和腸易激綜合征-C是折磨全世界數百萬患者的功能性胃腸病。","exchange":"NASDAQ","name":"Synergy Pharmaceuticals","nameEN":"Synergy Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":null}}